Leuprolide

- TRADE NAMES: Carcinil; Eligard (Sanofi-Aventis); Enantone; Leuprorelin; Lucrin; Lupron (TAP); Lupron Depot-Ped (AbbVie); Procren Depot; Procrin; Tapros; Viadur (Bayer)
- INDICATIONS: Prostate carcinoma, endometriosis
- SYNONYM: leuprorelin
- CLASS: Gonadotropin-releasing hormone (GnRH) agonist
- HALF-LIFE: 3–4 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
PREGNANCY CATEGORY: X
Please login to see the rest of this drug profile
SKIN.
HAIR.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GENITOURINARY.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations 
- Breast feeding
- Geriatric
- Pediatric